Benchmarking in vitro tissue-engineered blood-brain barrier models

被引:108
|
作者
DeStefano, Jackson G. [1 ,2 ]
Jamieson, John J. [1 ,3 ]
Linville, Raleigh M. [1 ,4 ]
Searson, Peter C. [1 ,2 ,5 ]
机构
[1] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, 120 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA
来源
基金
美国国家科学基金会;
关键词
Blood-brain barrier; Tissue-engineering; Induced pluripotent stem cells; Benchmarking; In vitro modeling; Brain microvascular endothelial cells; MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; ADVANCE TRANSLATIONAL RESEARCH; BASEMENT-MEMBRANE PROTEINS; WALL SHEAR-STRESS; ELECTRICAL-RESISTANCE; CEREBRAL MICROVESSELS; EXTRACELLULAR-MATRIX; SINGLE CAPILLARIES;
D O I
10.1186/s12987-018-0117-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The blood-brain barrier (BBB) plays a key role in regulating transport into and out of the brain. With increasing interest in the role of the BBB in health and disease, there have been significant advances in the development of in vitro models. The value of these models to the research community is critically dependent on recapitulating characteristics of the BBB in humans or animal models. However, benchmarking in vitro models is surprisingly difficult since much of our knowledge of the structure and function of the BBB comes from in vitro studies. Here we describe a set of parameters that we consider a starting point for benchmarking and validation. These parameters are associated with structure (ultrastructure, wall shear stress, geometry), microenvironment (basement membrane and extracellular matrix), barrier function (transendothelial electrical resistance, permeability, efflux transport), cell function (expression of BBB markers, turnover), and co-culture with other cell types (astrocytes and pericytes). In suggesting benchmarks, we rely primarily on imaging or direct measurements in humans and animal models.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] In vitro blood-brain barrier models: Current and perspective technologies
    Naik, Pooja
    Cucullo, Luca
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (04) : 1337 - 1354
  • [32] Membrane configuration optimization for in vitro blood-brain barrier models
    Wuest, Diane M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [33] Repairing the blood-brain barrier Engineered Wnt ligands specifically target blood-brain barrier function
    McMahon, Andrew P.
    Ichida, Justin K.
    SCIENCE, 2022, 375 (6582) : 715 - 716
  • [34] The blood-brain barrier as an endocrine tissue
    Banks, William A.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (08) : 444 - 455
  • [35] In vitro modelling of the blood-brain barrier
    Gosselet, Fabien
    M S-MEDECINE SCIENCES, 2017, 33 (04): : 423 - 431
  • [36] Designing in vitro Blood-Brain Barrier Models Reproducing Alterations in Brain Aging
    Osipova, Elena D.
    Komleva, Yulia K.
    Morgun, Andrey V.
    Lopatina, Olga L.
    Panina, Yulia A.
    Olovyannikova, Raissa Ya.
    Vais, Elizaveta F.
    Salmin, Vladimir V.
    Salmina, Alla B.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [37] Biology and Models of the Blood-Brain Barrier
    Hajal, Cynthia
    Le Roi, Baptiste
    Kamm, Roger D.
    Maoz, Ben M.
    ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 23, 2021, 2021, 23 : 359 - 384
  • [38] A guide for blood-brain barrier models
    Soliman, Yomna
    Al-khodor, Jana
    Koken, Gulnaz Yildirim
    Mustafaoglu, Nur
    FEBS LETTERS, 2025, 599 (05) : 599 - 644
  • [39] The application of in situ and in vitro models for screening blood-brain barrier permeation
    Read, KD
    JOURNAL OF NEUROCHEMISTRY, 2003, 85 : 7 - 7
  • [40] New approaches to in vitro models of blood-brain barrier drug transport
    Terasaki, T
    Ohtsuki, S
    Hori, S
    Takanaga, H
    Nakashima, E
    Hosoya, K
    DRUG DISCOVERY TODAY, 2003, 8 (20) : 944 - 954